Operating Expenses - AVROBIO Inc (NASDAQ:TECX) - Alpha Spread

AVROBIO Inc
NASDAQ:TECX

Watchlist Manager
AVROBIO Inc Logo
AVROBIO Inc
NASDAQ:TECX
Watchlist
Price: 19 USD 1.88% Market Closed
Market Cap: 279.9m USD
Have any thoughts about
AVROBIO Inc?
Write Note

AVROBIO Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

AVROBIO Inc
Operating Expenses Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
AVROBIO Inc
NASDAQ:TECX
Operating Expenses
-$71.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Operating Expenses
-$20.6B
CAGR 3-Years
-3%
CAGR 5-Years
-11%
CAGR 10-Years
-9%
Gilead Sciences Inc
NASDAQ:GILD
Operating Expenses
-$11.2B
CAGR 3-Years
1%
CAGR 5-Years
-4%
CAGR 10-Years
-10%
Amgen Inc
NASDAQ:AMGN
Operating Expenses
-$13.3B
CAGR 3-Years
-9%
CAGR 5-Years
-7%
CAGR 10-Years
-4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Operating Expenses
-$4.7B
CAGR 3-Years
-10%
CAGR 5-Years
-18%
CAGR 10-Years
-14%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Operating Expenses
-$7.5B
CAGR 3-Years
-23%
CAGR 5-Years
-14%
CAGR 10-Years
-18%

See Also

What is AVROBIO Inc's Operating Expenses?
Operating Expenses
-71.7m USD

Based on the financial report for Dec 31, 2023, AVROBIO Inc's Operating Expenses amounts to -71.7m USD.

What is AVROBIO Inc's Operating Expenses growth rate?
Operating Expenses CAGR 1Y
32%

Over the last year, the Operating Expenses growth was 32%.

Back to Top